Growth Metrics

Rockwell Medical (RMTI) Receivables - Other (2016 - 2022)

Rockwell Medical's Receivables - Other history spans 8 years, with the latest figure at $7.4 million for Q3 2022.

  • For Q3 2022, Receivables - Other rose 22.05% year-over-year to $7.4 million; the TTM value through Sep 2022 reached $7.4 million, up 22.05%, while the annual FY2021 figure was $5.9 million, 41.76% up from the prior year.
  • Receivables - Other reached $7.4 million in Q3 2022 per RMTI's latest filing, down from $8.1 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $8.1 million in Q2 2022 to a low of $5122.0 in Q3 2019.
  • Average Receivables - Other over 5 years is $4.6 million, with a median of $5.4 million recorded in 2021.
  • Peak YoY movement for Receivables - Other: plummeted 99.93% in 2019, then soared 80513.04% in 2020.
  • A 5-year view of Receivables - Other shows it stood at $7.0 million in 2018, then tumbled by 39.79% to $4.2 million in 2019, then dropped by 0.76% to $4.2 million in 2020, then surged by 41.76% to $5.9 million in 2021, then grew by 24.59% to $7.4 million in 2022.
  • Per Business Quant, the three most recent readings for RMTI's Receivables - Other are $7.4 million (Q3 2022), $8.1 million (Q2 2022), and $7.1 million (Q1 2022).